Fol. Biol. 2005, 51, 76-81
https://doi.org/10.14712/fb2005051030076
Are the T/C Polymorphism of the CYP17 Gene and the Tetranucleotide Repeat (TTTA) Polymorphism of the CYP19 Gene Genetic Markers for Premature Coronary Artery Disease in Caucasians?
References
1. , S. E., Economos, K., Miller, D., Simpson, E. R. (1994) CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. J. Clin. Endocrinol. Metabol. 79, 1831-1834.
2. , E., Bush, T. L. (1991) Estrogen and coronary heart disease in women. JAMA 265, 1861-1867.
<https://doi.org/10.1001/jama.1991.03460140089033>
3. , L. M., Imyatinov, E. N., Suspistin, E. N., Grigoriev, M. Y., Sokolov, E. P., Togo, A., Hanson, K. P., Poroshina, T. E., Vasiljev, D. A., Kovalevskij, A. Y., Gamajunova, V. B. (2001) CYP19 gene polymorphism in endometrial cancer patients. J. Cancer Res. Clin. Oncol. 127, 135-138.
<https://doi.org/10.1007/s004320000200>
4. , L. M., Imyatinov, E. N., Gamajunova, V. B., Kovalevskij, A. J., Kuligina, E. S., Belogubova, E. V., Buslov, K. G., Karpova, M. B., Togo, A. V., Volkov, O. N., Kovalenko, I. G. (2002) CYP17 genetic polymorphism in endometrial cancer: are only steroids involved? Cancer Lett. 180, 47-53.
<https://doi.org/10.1016/S0304-3835(02)00019-8>
5. , C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, S. K., Simpson, E. R. (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 337, 91-95.
<https://doi.org/10.1056/NEJM199707103370204>
6. , J. A., Gutani, J. P., Glynn, N. W., Paternostro-Bayles, M., Cottington, E., Kuller, L. H. (1992) Serum estrone concentrations and coronary artery disease in postmenopausal women. Arterioscler. Thromb. 14, 14-18.
<https://doi.org/10.1161/01.ATV.14.1.14>
7. , H. S., Coetzee, G. A., Kolonel, L. N., Ross, R. K., Henderson, B. E. (1997) A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res. 57, 1063-1065.
8. , H., Shames, L. S., Pike, M. C., Coetzee, G. A., Stanczyk, F. Z., Henderson, B. E. (1998) Cytochrome P450c17αgene (CYP17) polymorphism is associated with serum estrogen and progesterone concentration. Cancer Res. 58, 585-587.
9. , C. A., Hankinson, S. E., Speizer, F. E., Hunter, D. J. (1999) A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Proc. Am. Assoc. Cancer Res. 40, 19.
10. , C. A., Hankinson, S. E., Spiegelman, D., Colditz, G. A., Willett, W. C., Speizer, F. E., Kelsey, T. K., Hunter, D. J. (1999) The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res. 59, 1015-1020.
11. , C. A., Stampfer, M. J., Giovannucci, E., Ma, J., Decalo, N. E., Kantoff, P. W., Hunter, D. J. (2001) The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer. Cancer Epidemiol. Biomarkers Prev. 10, 743-748.
12. , N., Sasano, H., Murakami, H., Ohkuma, T., Nagura, H., Takagi, Y. (1999) Localized expression of aromatase in human vascular tissues. Circ. Res. 84, 1285-1291.
<https://doi.org/10.1161/01.RES.84.11.1285>
13. , C. S., Dunning, A. M., Durocher, F., Teare, D., Pharoah, P. D., Luben, R. N., Easton, D. F., Ponder, B. A. (2000) Polymorphism in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk. Carcinogenesis 21, 189-193.
<https://doi.org/10.1093/carcin/21.2.189>
14. , J. T., Jones, K. A., Tjian, R. (1986) Promoter-specific activation of RNA polymerase II transcription by SpI. Trends Biochem. Sci. 11, 20-23.
<https://doi.org/10.1016/0968-0004(86)90226-4>
15. , R. H. (1998) Cardiovascular effects of endogenous and exogenous sex hormones over a woman’s lifetime. Am. J. Obstet. Gynecol. 158, 1630-1643.
<https://doi.org/10.1016/0002-9378(88)90201-3>
16. , E. S., Togo, A. V., Sispitsin, E. N., Grigorjev, M. Y., Pozharisskiy, K. M., Chagunava, O. L., Bernstein, L. M., Theilet, C., Hanson, K. P., Imyanitov, E. N. (2000) CYP17 polymorphism in the group of distinct breast cancer susceptibility: comparison of patients with the bilateral vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women. Cancer Lett. 156, 45-50.
<https://doi.org/10.1016/S0304-3835(00)00436-5>
17. , C. K., Ebrahim, H., Tennant, S., Flanagan, A. M. (1997) Aromatase cytochrome P450 transcripts are detected in fractured human bone but not in normal skeletal tissue. Bone 21, 433-440.
<https://doi.org/10.1016/S8756-3282(97)00168-3>
18. , M., Karas, R. (1999) The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340, 1801-1811.
<https://doi.org/10.1056/NEJM199906103402306>
19. , W. L. (1988) Molecular biology of steroid hormone synthesis. Endocr. Rev. 9, 295-318.
<https://doi.org/10.1210/edrv-9-3-295>
20. Miller, W. R. (1996) Estrogen and breast cancer. Landes, Austin, pp. 207.
21. , H., Harada, N., Sasano, H. (2001) Aromatase in atherosclerotic lesions of human aorta. J. Steroid Biochem. Mol. Biol. 79, 67-74.
<https://doi.org/10.1016/S0960-0760(01)00128-5>
22. , S., Shivley, J. E., Yuan, P., Hall, P. F. (1981) Microsomal cytochrome P-450 from neonatal pig testis. Two enzymatic activites (17α-hydroxylase and C17,20 lyase) associated with one protein. Biochemistry 20, 4037-4042.
<https://doi.org/10.1021/bi00517a014>
23. , G. B., Pinkernell, B. H., Jing, T. J. (1994) The association of hypotestosteronemia with coronary artery disease in men. Arterioscler. Thromb. 14, 701-706.
<https://doi.org/10.1161/01.ATV.14.5.701>
24. , G., Kirbis, J., Milutinovic A. (2004) The -455G/A polymorphism of the β fibrinogen gene and the Bgl II polymorphism of the α2β1 integrin gene and myocardial infarction in patients with type 2 diabetes. Folia Biol. (Praha) 50, 203-204.
25. , H., Harada, N. (1998) Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocrine Rev. 19, 593-607.
26. , M., Anderson, A. O., Johanson, J. E., Wadelius, C., Rane, E. (1999) Prostate cancer associated with CYP17 genotype. Pharmacogenetics 9, 635-639.
